Cargando…

Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome

BACKGROUND: Patients with metabolic syndrome (MetS) are at increased risk of asymptomatic hyperuricemia (i.e., elevated serum uric acid (SUA) level without gout) and cardiovascular disease. We conducted a cross-sectional study to examine associations between SUA levels and coronary flow reserve and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seoyoung C., Di Carli, Marcelo F., Garg, Rajesh K., Vanni, Kathleen, Wang, Penny, Wohlfahrt, Alyssa, Yu, Zhi, Lu, Fengxin, Campos, Anarosa, Bibbo, Courtney F., Smith, Stacy, Solomon, Daniel H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390615/ https://www.ncbi.nlm.nih.gov/pubmed/30886968 http://dx.doi.org/10.1186/s41927-018-0027-6

Ejemplares similares

Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT
por: Wang, Penny, et al.
Publicado: (2018)

Assessment of coronary vascular function with cardiac PET in relation to serum uric acid
por: Kim, Seoyoung C., et al.
Publicado: (2018)

Use of rheumatology-specific patient navigators to understand and reduce barriers to medication adherence: Analysis of qualitative findings
por: Wohlfahrt, Alyssa, et al.
Publicado: (2018)

Prior SARS‐CoV‐2 Infection Is Associated With Coronary Vasomotor Dysfunction as Assessed by Coronary Flow Reserve From Cardiac Positron Emission Tomography
por: Weber, Brittany, et al.
Publicado: (2022)

Coronary Flow Reserve, Inflammation, and Myocardial Strain: The CIRT-CFR Trial
por: Taqueti, Viviany R., et al.
Publicado: (2022)

To treat or not to treat asymptomatic hyperuricemia in chronic kidney disease
por: Shin, Dong Ho
Publicado: (2019)

Relationship between oxidative stress and inflammation in hyperuricemia: Analysis based on asymptomatic young patients with primary hyperuricemia
por: Zhou, You, et al.
Publicado: (2018)

Gut Microbiota Characterization in Patients with Asymptomatic Hyperuricemia: probiotics increased
por: Yang, Hai-Tao, et al.
Publicado: (2021)

Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities
por: Wu, Junnan, et al.
Publicado: (2017)

Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
por: Waheed, Yousuf, et al.
Publicado: (2021)

Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial
por: Eleftheriadis, Theodoros, et al.
Publicado: (2017)

Asymptomatic Hyperuricemia Associates with Cardiometabolic Risk Indicators in Overweight/Obese but Not in Lean Adolescents
por: Sebekova, Katarina, et al.
Publicado: (2020)

Comparison of Benzbromarone and Allopurinol on Primary Prevention of the First Gout Flare in Asymptomatic Hyperuricemia
por: Lai, Shih-Wei, et al.
Publicado: (2022)

Gegen Qinlian Decoction treatment of asymptomatic hyperuricemia by targeting circadian immune function
por: Wang, Xiaojun, et al.
Publicado: (2023)

Asymptomatic hyperuricemia associated with increased risk of nephrolithiasis: a cross-sectional study
por: Deng, Haoyuan, et al.
Publicado: (2023)

Association between Asymptomatic Hyperuricemia with Adiposity Indices: A Cross-Sectional Study in a Spanish Population
por: Sánchez-Bacaicoa, Carmen, et al.
Publicado: (2023)

Prognostic value of calcium score and coronary flow velocity reserve in asymptomatic diabetic patients
por: Dikic, Miodrag, et al.
Publicado: (2015)

Physicians’ perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey
por: Cha, Ran-hui, et al.
Publicado: (2019)

Allopurinol-induced hypersensitivity syndrome followed by painless thyroiditis in a patient with asymptomatic hyperuricemia
por: Chen, Xiaolin, et al.
Publicado: (2020)

Asymptomatic Hyperuricemia and Metabolically Unhealthy Obesity: A Cross-Sectional Analysis in the Tianning Cohort
por: Yu, Jia, et al.
Publicado: (2021)

Association Between the Cardiometabolic Index and Hyperuricemia in an Asymptomatic Population with Normal Body Mass Index
por: Zuo, Yu-Qiang, et al.
Publicado: (2021)

Asymptomatic Hyperuricemia Promotes Recovery from Ischemic Organ Injury by Modulating the Phenotype of Macrophages
por: Gnemmi, Viviane, et al.
Publicado: (2022)

Effect of Asymptomatic Hyperuricemia on Mortality of Elderly Patients After Elective Percutaneous Coronary Intervention
por: Chen, Chen, et al.
Publicado: (2022)

A metabonomic study to explore potential markers of asymptomatic hyperuricemia and acute gouty arthritis
por: Wang, Wei, et al.
Publicado: (2023)

Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study
por: Pineda, Carlos, et al.
Publicado: (2011)

Distinct Gut Microbiota in Patients with Asymptomatic Hyperuricemia: A Potential Protector against Gout Development
por: Kim, Hye Won, et al.
Publicado: (2022)

Medical Students’ Perspective and Knowledge of Asymptomatic Hyperuricemia and Gout Management: A Cross-Sectional Study
por: Zuzic Furlan, Sanja, et al.
Publicado: (2021)

Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout
por: Zhang, Yannan, et al.
Publicado: (2018)

Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review
por: Ramirez, Maria Erika G., et al.
Publicado: (2017)

Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial
por: Tanaka, Atsushi, et al.
Publicado: (2020)

The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study
por: Liang, Jing, et al.
Publicado: (2020)

Acupuncture to treat asymptomatic hyperuricemia: A protocol for systematic review and meta-analysis of randomized controlled trials
por: Hwang, Ji Hye, et al.
Publicado: (2021)

A coronary artery disease-associated SNP rs6903956 contributed to asymptomatic hyperuricemia susceptibility in Han Chinese
por: Meng, Jianfen, et al.
Publicado: (2015)

Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study
por: Nossent, Johannes, et al.
Publicado: (2016)

A Head-To-Head Comparison of Benzbromarone and Allopurinol on the Risk of Type 2 Diabetes Mellitus in People With Asymptomatic Hyperuricemia
por: Lai, Shih-Wei, et al.
Publicado: (2021)

Effect of febuxostat on left ventricular diastolic function in patients with asymptomatic hyperuricemia: a sub analysis of the PRIZE Study
por: Kusunose, Kenya, et al.
Publicado: (2021)

Long-Term Effect of Febuxostat on Endothelial Function in Patients With Asymptomatic Hyperuricemia: A Sub-Analysis of the PRIZE Study
por: Maruhashi, Tatsuya, et al.
Publicado: (2022)

Knowledge and Practice of Primary Health Care Providers in the Management of Asymptomatic Hyperuricemia and Gout in the Qassim Region of Saudi Arabia
por: Alraqibah, Elias A, et al.
Publicado: (2022)

Rapid identification of early renal damage in asymptomatic hyperuricemia patients based on urine Raman spectroscopy and bioinformatics analysis
por: Kong, Xiaodong, et al.
Publicado: (2023)

Asymptomatic Hyperuricemia Is Associated with Achilles Tendon Rupture through Disrupting the Normal Functions of Tendon Stem/Progenitor Cells
por: Liang, Jingjing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hi21j7ki9fn3kbf7uhmdon1lbs